Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for GRAIL, Inc. (GRAL : NSDQ)

• Company Description    GRAIL LLC is a biotechnology company. It focuses on developing technologies for early cancer detection. GRAIL LLC is based in Menlo Park, United States. Number of Employees: 910

• Price / Volume Information    Yesterday's Closing Price: $79.10 Daily Weekly Monthly 20 Day Moving Average: 582,504 shares Shares Outstanding: 44.67 (millions) Market Capitalization: $3,533.10 (millions) Beta: 3.25 52 Week High: $118.84 52 Week Low: $35.39 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 4.80% 5.54% 12 Week 35.70% 32.83% Year To Date -7.58% -17.56%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 1525 O`BRIEN DRIVE - MENLO PARK,CA 94025 USA ph: 833-694-2553 fax: - ir@grailbio.com https://grail.com

• General Corporate Information    Officers Robert Ragusa - Chief Executive Officer Gregory Summe - Chairperson of the Board Aaron Freidin - Chief Financial Officer William Chase - Director Steven Mizell - Director Peer Information GRAIL, Inc. (CORR.) GRAIL, Inc. (RSPI) GRAIL, Inc. (CGXP) GRAIL, Inc. (BGEN) GRAIL, Inc. (GTBP) GRAIL, Inc. (RGRX) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-BIOMED/GENE Sector: Medical CUSIP: 384747101 SIC: 8071 Fiscal Year Fiscal Year End: December Last Reported Quarter: 06/01/26 Next Expected EPS Date: 11/11/26 Share - Related Items Shares Outstanding: 44.67 Most Recent Split Date: (:1) Beta: 3.25 Market Capitalization: $3,533.10 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-2.84 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-10.41 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 3.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 11/11/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 1.34 Price/Cash Flow: - Price / Sales: 21.38 EPS Growth vs. Year Ago Period: 19.50% vs. Previous Quarter: -11.79% Sales Growth vs. Year Ago Period: 25.72% vs. Previous Quarter: 9.57% ROE 06/30/26 - -15.88 03/31/26 - -16.42 12/31/25 - -17.11 ROA 06/30/26 - -14.02 03/31/26 - -14.34 12/31/25 - -14.75 Current Ratio 06/30/26 - 10.95 03/31/26 - 11.74 12/31/25 - 11.97 Quick Ratio 06/30/26 - 10.95 03/31/26 - 11.74 12/31/25 - 11.97 Operating Margin 06/30/26 - -236.95 03/31/26 - -253.22 12/31/25 - -277.46 Net Margin 06/30/26 - -236.95 03/31/26 - -253.22 12/31/25 - -277.46 Pre-Tax Margin 06/30/26 - -320.38 03/31/26 - -330.27 12/31/25 - -363.18 Book Value 06/30/26 - 59.25 03/31/26 - 58.27 12/31/25 - 66.13 Inventory Turnover 06/30/26 - - 03/31/26 - - 12/31/25 - - Debt-to-Equity 06/30/26 - 0.00 03/31/26 - 0.00 12/31/25 - 0.00 Debt-to-Capital 06/30/26 - 0.00 03/31/26 - 0.00 12/31/25 - 0.00

Powered by Zacks Investment Research ©